1. Home
  2. SBSW vs RGEN Comparison

SBSW vs RGEN Comparison

Compare SBSW & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D/B/A Sibanye-Stillwater Limited ADS

SBSW

D/B/A Sibanye-Stillwater Limited ADS

HOLD

Current Price

$13.19

Market Cap

8.8B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$158.91

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBSW
RGEN
Founded
2013
1981
Country
South Africa
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SBSW
RGEN
Price
$13.19
$158.91
Analyst Decision
Buy
Buy
Analyst Count
2
10
Target Price
$6.90
$170.90
AVG Volume (30 Days)
4.8M
723.7K
Earning Date
08-28-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$6,290,132,787.00
$707,890,000.00
Revenue This Year
$14.61
$17.84
Revenue Next Year
$15.74
$12.57
P/E Ratio
N/A
$6,353.06
Revenue Growth
3.11
11.74
52 Week Low
$3.05
$102.97
52 Week High
$13.40
$182.52

Technical Indicators

Market Signals
Indicator
SBSW
RGEN
Relative Strength Index (RSI) 64.47 49.06
Support Level $12.10 $160.11
Resistance Level $12.81 $165.02
Average True Range (ATR) 0.52 4.83
MACD 0.05 -1.19
Stochastic Oscillator 66.67 3.00

Price Performance

Historical Comparison
SBSW
RGEN

About SBSW D/B/A Sibanye-Stillwater Limited ADS

Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: